Neurology® Podcast
Eligibility for Anti-Amyloid Treatment
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:23:27
- Mas informaciones
Informações:
Sinopsis
Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment. Read the related article in Neurology. Visit NPUb.org/Podcast for associated article links.
